Back to REGN
WestEnd Advisors, LLC REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$21.2M
Q3 2026
Peak value
$21.2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $5K |
| Q1 2026 | $19.8M |
| Q2 2026 | $12.1M |
| Q3 2026 | $21.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $21.2M | 27.9K | — | — |
| Q2 2026 | $12.1M | 19.4K | — | — |
| Q1 2026 | $19.8M | 25.6K | — | — |
| Q4 2025 | $5K | 7 | — | — |
Other funds holding REGN
$6.2B
$5.7B
$5.2B
$5.1B
$4.7B
$4.7B
$4.5B
$4.3B
Other WestEnd Advisors, LLC positions
STT-PG
$655.2MSELECT SECTOR SPDR TR SBI INT-
STT-PG
$640.2MSELECT SECTOR SPDR TR SBI INT-
STT-PG
$464.4MSELECT SECTOR SPDR TR SBI INT-
STT-PG
$457.1MSELECT SECTOR SPDR TR SBI INT-
STT-PG
$435.9MSELECT SECTOR SPDR TR SBI INT-
STT-PG
$428.4MSELECT SECTOR SPDR TR SBI INT-
STT-PG
$383.3MSELECT SECTOR SPDR TR SBI INT-
ETHA
$364MISHARES TR CORE MSCI EURO